(Q34357888)

English

Influence of debrisoquine oxidation phenotype on exercise tolerance and subjective fatigue after metoprolol and atenolol in healthy subjects

scientific article published in April 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Influence of debrisoquine oxidation phenotype on exercise tolerance and subjective fatigue after metoprolol and atenolol in healthy subjects (English)

1 reference

Europe PubMed Central

1 August 2017

author name string

Lewis RV

1

1 reference

Europe PubMed Central

1 August 2017

Ramsay LE

2

1 reference

Europe PubMed Central

1 August 2017

Jackson PR

3

1 reference

Europe PubMed Central

1 August 2017

Yeo WW

4

1 reference

Europe PubMed Central

1 August 2017

Lennard MS

5

1 reference

Europe PubMed Central

1 August 2017

Tucker GT

6

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

1 April 1991

1 reference

Europe PubMed Central

1 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

1 August 2017

31

1 reference

Europe PubMed Central

1 August 2017

391-398

1 reference

Europe PubMed Central

1 August 2017

4

1 reference

Europe PubMed Central

1 August 2017

Interindividual variations in metoprolol metabolism--some clinical and other observations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368323

6 July 2018

Adverse effects from metoprolol are not generally associated with oxidation status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368323

6 July 2018

Beta blockers and fatigue.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368323

6 July 2018

Quantification of side-effects of beta-adrenoceptor blockers using visual analogue scales

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368323

6 July 2018

Comparison of two slow-release formulations of metoprolol with conventional metoprolol and atenolol in hypertensive patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368323

6 July 2018

Variability in the pharmacokinetics of atenolol and metoprolol.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368323

6 July 2018

Severe complications of antianginal drug therapy in a patient identified as a poor metabolizer of metoprolol, propafenone, diltiazem, and sparteine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368323

6 July 2018

Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368323

6 July 2018

Timolol and atenolol: relationships between oxidation phenotype, pharmacokinetics and pharmacodynamics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368323

6 July 2018

Side-effects of beta-adrenoceptor blocking drugs assessed by visual analogue scales

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368323

6 July 2018

The effect of beta-adrenoceptor blockade on factors affecting exercise tolerance in normal man

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368323

6 July 2018

Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1991.TB05551.X

21 January 2018

Adverse drug reaction reporting and retrospective phenotyping for oxidation polymorphism

1 reference

https://pubmed.ncbi.nlm.nih.gov/2049246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2049246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High plasma concentrations of beta-receptor blocking drugs and deficient debrisoquine hydroxylation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2049246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxidation phenotype--a major determinant of metoprolol metabolism and response

1 reference

https://pubmed.ncbi.nlm.nih.gov/2049246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protecting the poor metaboliser--from what?

1 reference

https://pubmed.ncbi.nlm.nih.gov/2049246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2125.1991.TB05551.X

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34357888&oldid=1548022736"